Syngene

Sukumaran joined Syngene in October 2017 as the Chief of Staff and was responsible for driving key strategic initiatives across…

With the accelerated approval of 38 additional manufacturing sites, the number of approved manufacturing sites of remdesivir in…

The stakeholders highlight the changes needed in the Indian regulatory system to meet changing demands, emerging concerns, at…

The company posted quarterly revenue of Rs. 437 Cr, in line with guidance: Profit After Tax, was impacted less than expected, at…

Zydus Cadila, Cadila Pharma, Biocon, Syngene, Glenmark, Serum Institute of India, Ipca, Strides are using LSSSDC’s programmes to…

EBITDA up 10 per cent to Rs 173 crores; the company also separates the roles of managing director and chairperson

EBITDA up 51 per cent at Rs 462 crores, net profit (excluding exceptional item) up 86 per cent at Rs 223 crores, small molecules…

Revenue up four per cent to Rs 441 crores, Profit After Tax increases nine per cent to Rs 72 crores. Further, Dr Mahesh Bhalgat…

Offer allows Biocon to monetise its shareholding in Syngene